glp-1 and addiction Weight-Loss Drugs Could Address a Range of Addictions The role of glucagon‐like peptide

It works by calming inflammatory responses within the body, making it particularly effective for gut health issues like IBD and for reducing skin inflammation associated with conditions like psoriasis

In this study, we established an obesity (induced by HFD)-related AF mice model, which showed increased AF vulnerability and exhibited apparent atrial structural remodeling (Figures 1, 2)

Finally, long-term consequences of NP exposure can limit clinical adoption

**BPC-157, a synthetic gastric pentadecapeptide studied primarily in animal models for tissue repair, gut healing, and anti-inflammatory effects, remains unapproved by the FDA as a finished drug with only limited small-scale human data available.** It was placed in Category 2 in 2023 due to concerns over immunogenicity, peptide impurities, and insufficient safety information for compounding under Section 503A